Kroker Equity Research

Kroker Equity Research

Share this post

Kroker Equity Research
Kroker Equity Research
#94 Worlds best Stocks - Ep.8
Copy link
Facebook
Email
Notes
More

#94 Worlds best Stocks - Ep.8

10 Under-the-Radar European Small-Cap Stocks to Watch

Kroker Equity Research's avatar
Kroker Equity Research
May 04, 2025
∙ Paid
6

Share this post

Kroker Equity Research
Kroker Equity Research
#94 Worlds best Stocks - Ep.8
Copy link
Facebook
Email
Notes
More
3
Share

When it comes to finding long-term winners in the stock market, small-cap companies often offer the most compelling opportunities. They tend to be more agile, under-the-radar, and, when chosen carefullycapable of delivering outsized returns over time. In this post, I’ve handpicked 10 promising small-cap stocks from across Europe, focusing on companies with strong return on capital, sound business models, and significant long-term potential. These aren’t the usual names you see headlining major investment reports, instead, they’re quietly profitable, often niche market leaders that are still flying below the radar. From a Danish cell counter used in biotech labs to a Spanish sausage casing powerhouse, each of these companies has something unique to offer and might just deserve a closer look.

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.


  • ATOSS Software (ETR: AOF) – Germany: A specialist in workforce management software that helps companies optimize staffing and time tracking. ATOSS enjoys exceptional profitability with strong margins and a globally leading niche position in its field, giving it the firepower to keep innovating and growing. Despite its success, it remains under-followed outside its home market, making it an intriguing under-the-radar play for long-term investors.

    • Revenue: €170.6 million

    • Operating Income (EBIT): €63.6 million

    • Net Income: €45.5 million

    • Market Cap: Approximately €2,1 billion

ATOSS Software SE (AOF) delivered an outstanding ROIC of 71.05% in 2024, with net income and free cash flow margins of 26.64% and 34.31% respectively, clear evidence of its highly efficient, scalable SaaS model (Source: TIKR.com).

  • Bioventix (LON: BVXP) – United Kingdom: Bioventix produces specialized “sheep monoclonal” antibodies used in diagnostic blood tests. It runs an outrageously high-margin, royalty-driven business model with gross margins over 90% and ROIC exceeding 88%, illustrating its quality economics. This niche biotech is hardly a household name, yet its consistent growth and cash generation make it a compelling secret pick in the healthcare space.

    • Revenue: GBP 13.6 Million

    • Operating Income (EBIT): GBP 10.6 million

    • Net Income: GBP 8.1 million

    • Market Cap: Approximately GBP 139 million

Bioventix PLC (BVXP) reported exceptional metrics in 2024, including an 88.53% ROIC and over 60% net and free cash flow margins, reaffirming the strength of its high-margin antibody royalty business (Source: TIKR.com).


  • Inficon (SWX: IFCN) – Switzerland: Inficon builds high-precision vacuum instruments and gas leak detectors used in semiconductors, refrigeration, and even environmental monitoring. It dominates its niches with over 50% market share in many of its product lines and has delivered exceptional returns on capital (historically an average ROIC above 30%. Despite its global reach in critical industries, this Swiss firm flies under most investors’ radars, even as it steadily compounds earnings.

    • Revenue: CHF 670.9 Million

    • Operating Income (EBIT): CHF 136.0 million

    • Net Income: CHF 112.8 million

    • Market Cap: Approximately CHF 2,185 million

INFICON Holding AG (IFCN) posted strong financials in 2024 with a 16.80% ROIC, a robust 31.49% net income margin, and solid cash flow generation, reflecting its niche leadership in precision instrumentation (Source: TIKR.com).

  • Esker (EPA: ALESK) – France: Esker is a cloud software provider that automates finance and procurement paperwork – think electronic invoicing and order management. Its subscription-based model drives steady double-digit growth (2024 sales reached €205 million, a 15% increase, with SaaS now 82% of revenue. This Paris-headquartered SaaS player has a solid recurring revenue engine and a global customer base, yet remains relatively undiscovered outside European tech circles.

    • Revenue: €203.0 Million

    • Operating Income (EBIT): €20.6 million

    • Net Income: €16.7 million

    • Market Cap: Approximately €1,649 million

Esker SA (ALESK) showed a respectable ROIC of 15.02% in 2024, with margins just under 8%, signaling stable performance in a competitive SaaS landscape (Source: TIKR.com).

The first four companies are available to all subscribers. The remaining six are exclusive to paid members, but worth everyone’s attention. I’ll be publishing deep dives on each of these businesses in the coming months, so stay tuned. For now, let’s take a closer look at the rest of the list.

Keep reading with a 7-day free trial

Subscribe to Kroker Equity Research to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Bernhard Kroker
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More